WHO wants global system for tracking clinical trials

	Tweet

The World Health Organisation (WHO) will seek support for a system to keep track of clinical trials at its Ministerial Summit on Health Research in Mexico next week (16-20 November). The system would form an Internet-based means of accessing registers of clinical trials around the world. The WHO also wants to create a system allowing individual trials to be identified and tracked.

The system has been proposed as a way of reducing the duplication of trials. Researchers and patient advocates have been lobbying for a global register as a means of bringing more information about clinical trails — especially those undertaken by pharmaceutical companies — into the public domain. The WHO would establish minimum standards on what information to include in the each registry.

Registries of clinical trials are starting to garner support after recent scandals about important unpublished data about safety of antidepressants that were already on the market. Financing hurdles might make it difficult for clinical trial data from developing countries to be incorporated into a global system.

RELATED STORIES:
Medicaid cure to be headache   DuPont sued in Teflon class action case   Silica issue clouds outlook for asbestos bill   Johnny wants a pet turtle? Just say no   More than half of Americans use Internet for health   Australian pair wins medicine Nobel   Polio campaign on track despite Saudi case: WHO   Polish health minister to stay on despite setback   One billion people cannot afford healthcare: WHO   Bush urges Libya to free condemned Bulgarian nurses   Senator resisting cut in asbestos claims fund   Is hand washing enough to stop the spread of disease?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]